Literature DB >> 18836616

Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.

Corina Radu1, Mircea Grigorescu, Dana Crisan, Monica Lupsor, Diana Constantin, Liliana Dina.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) have become important health issues in many countries. There is increasing interest in ultrasound-diagnosed NAFLD. The aim of the study was to evaluate the prevalence of NAFLD in hospitalized patients and to determine the metabolic features of ultrasound-diagnosed patients.
METHODS: A number of 3,005 hospitalized patients were prospectively assessed. Subjects were submitted to a standard interview and a chart review was made to note anthropometric (BMI and waist circumference), biochemical and abdominal ultrasonography parameters. MS was evaluated according to IDF criteria. Logistic regression analysis was used to identify independent factors associated with ultrasound-diagnosed NAFLD.
RESULTS: The prevalence of NAFLD in the enrolled subjects was 20%. Patients with NAFLD had higher values of BMI and waist circumference. MS was present in 61.09 % of cases with NAFLD. At least one risk factor was observed in 88.41%, and in 14.07% of patients all 5 criteria were fulfilled. The odds ratios of the metabolic disorders in subjects with NAFLD compared with those without NAFLD were higher in the overweight and obese group than in the normal-weight group. Central obesity, hypertriglyceridemia, and elevated blood pressure (for total and the overweight group) were independently associated with NAFLD.
CONCLUSION: The prevalence of ultrasound NAFLD in hospitalized patients was similar to the general population. NAFLD was closely associated with metabolic disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18836616

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  15 in total

1.  Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children.

Authors:  Yan-Ping Xu; Li Liang; Chun-Lin Wang; Jun-Fen Fu; Pei-Ning Liu; Lan-Qiu Lv; Yi-Min Zhu
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 2.  Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.

Authors:  W Nseir; A Shalata; A Marmor; N Assy
Journal:  Dig Dis Sci       Date:  2011-06-08       Impact factor: 3.199

3.  Familial Mediterranean fever: an association with non-alcoholic fatty liver disease.

Authors:  Doron Rimar; Itzhak Rosner; Michael Rozenbaum; Eli Zuckerman
Journal:  Clin Rheumatol       Date:  2011-03-02       Impact factor: 2.980

4.  Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.

Authors:  Masahide Hamaguchi; Noriyuki Takeda; Takao Kojima; Akihiro Ohbora; Takahiro Kato; Hiroshi Sarui; Michiaki Fukui; Chisato Nagata; Jun Takeda
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 5.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.

Authors:  Ayaka Hamabe; Hirofumi Uto; Yasushi Imamura; Ken Kusano; Seiichi Mawatari; Kotaro Kumagai; Takeshi Kure; Tsutomu Tamai; Akihiro Moriuchi; Toshio Sakiyama; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2011-02-08       Impact factor: 7.527

7.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

8.  Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

9.  Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus.

Authors:  Yukiko Kobayashi; Hina Tatsumi; Mikako Hattori; Hiroki Sugiyama; Sayori Wada; Masashi Kuwahata; Saiyu Tanaka; Kazuyuki Kanemasa; Yoshio Sumida; Yuji Naito; Michiaki Fukui; Yasuhiro Kido
Journal:  J Clin Biochem Nutr       Date:  2016-08-19       Impact factor: 3.114

10.  Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.

Authors:  Eline H van den Berg; Marzyeh Amini; Tim C M A Schreuder; Robin P F Dullaart; Klaas Nico Faber; Behrooz Z Alizadeh; Hans Blokzijl
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.